Nutrition in general and the blood glucose metabolism plays a pivotal role in the development of obesity, type 2 diabetes and its consequences, such as cancer, stroke and heart attack.²
We estimated that over 3.2 billion people suffer from diseases related to nutrition with more than 11 million deaths per year.³
More than 6.8 trillion USD p.a. in economic cost are attributed to diseases that could be alleviated with digital therapeutics.¹
At Perfood we develop digital therapeutics with personalized low-glycemic diet as “active ingredient”. We apply our patent-pending technology and combine it with digital coaching. With this, we improve the direct health condition of patients. But more than that, we educate patients and guide them through lasting behavioral change. 80% of our users state to adhere to their personalized low-glycemic diet event years after using one of our products.⁴
Personalized low-glycemic diet addresses the root cause of many diseases. This is why we are often able to reduce comorbidities on top of the primary outcome.
For health plans, we offer pricing packages tailored to your organization. Are you looking for innovative value based compensation schemes? Talk to us. Do you prefer traditional volume-based plans? No problem at all.
With digital therapeutics from Perfood we help you maximized short-term ROI – short- and long-term.
Want to find out more?
1) 3.4 trillion in the USA extrapolated to Europe and the USA, https://www.mckinsey.com/industries/life-sciences/our-insights/digital-therapeutics-and-pharma-a-blueprint-for-success-from-sanofis-bozidar-jovicevic
2) European Prospective Investigation Into Cancer and Nutrition-Potsdam study. 2019.
3) Perfood estimate based on epidemiological data from various studies.; GBD 2017 Diet Collaborators. Lancet. 2019 May 11;393(10184):1958-1972.
4) 1 n = 49; real-world evidence from sinCephalea